Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
03 Aug 2024
Historique:
received: 28 06 2024
revised: 31 07 2024
accepted: 31 07 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 10 8 2024
Statut: epublish

Résumé

Pathogenic variations in the fused in sarcoma (

Identifiants

pubmed: 39126066
pii: ijms25158495
doi: 10.3390/ijms25158495
pii:
doi:

Substances chimiques

Oligonucleotides, Antisense 0
RNA-Binding Protein FUS 0
FUS protein, human 0
Morpholinos 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Motor Neurone Disease Research Australia
ID : 2322

Auteurs

Rita Mejzini (R)

Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia.
The Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.

Marvin H Caruthers (MH)

Department of Biochemistry, University of Colorado, Boulder, CO 80309, USA.

Balazs Schafer (B)

Department of Biochemistry, University of Colorado, Boulder, CO 80309, USA.

Ondrej Kostov (O)

Department of Biochemistry, University of Colorado, Boulder, CO 80309, USA.

Kavitha Sudheendran (K)

Department of Biochemistry, University of Colorado, Boulder, CO 80309, USA.

Marija Ciba (M)

Department of Biochemistry, University of Colorado, Boulder, CO 80309, USA.

Mathias Danielsen (M)

Department of Biochemistry, University of Colorado, Boulder, CO 80309, USA.

Steve Wilton (S)

Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia.
The Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.
Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Crawley, WA 6009, Australia.

Patrick Anthony Akkari (PA)

Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia.
The Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.
Black Swan Pharmaceuticals, Wake Forest, NC 27587, USA.
Department of Neurology, Duke University, Durham, NC 27708, USA.

Loren L Flynn (LL)

Centre for Molecular Medicine and Innovative Therapeutics, Health Futures Institute, Murdoch University, Murdoch, WA 6150, Australia.
The Perron Institute for Neurological and Translational Science, Nedlands, WA 6009, Australia.
Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Crawley, WA 6009, Australia.
Black Swan Pharmaceuticals, Wake Forest, NC 27587, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH